|
|
||||||||
The Journal of Immunology, Vol 146, Issue 2 648-655, Copyright © 1991 by American Association of Immunologists
ARTICLES |
SA Stacker and TA Springer
Department of Pathology, Harvard Medical School, Boston, MA 02115.
p150,95 is a member of the beta 2 family of integrins, which includes both LFA-1 and Mac-1. These molecules are known to play a role in the adhesion of lymphocytes, granulocytes, and monocytes to various cell types including vascular endothelium. p150,95 is presumed to have an adhesive function because of its structural relationship to the other beta 2 integrins and the ability of anti-p150,95 mAb to inhibit some myeloid cell interactions with tumor cells, endothelial cells, and other substrates. In an endeavor to demonstrate directly that p150,95 can act as an adhesion molecule, we raised a mAb (CBRp150/4G1) to the alpha subunit of p150,95, which allows for the purification of functional intact p150,95 heterodimers. The antibody was selected by using a high pH elution ELISA. The assay was designed to select for antibodies directed to the alpha-chain of p150,95, which could be readily dissociated from p150,95 under conditions of high pH and 2 mM MgCl2. p150,95 purified under these conditions with CBRp150/4G1- Sepharose could be immunoprecipitated by using antibodies to the alpha- and beta-chains of p150,95 indicating that the structural integrity of the heterodimer was preserved during purification and elution. Elution in the absence of divalent cations yielded primarily dissociated alpha and beta subunits. Other antibodies previously made to p150,95 alpha- chain such as SHCL3 were greatly reduced in their efficiency of yielding intact heterodimer under these conditions. Mapping of the epitopes by using chimeric molecules of p150,95/Mac-1 revealed that antibodies that react with the divalent cation sites of p150,95 are inferior for the purification of intact p150,95. The adhesive capacity of p150,95 was demonstrated by the specific binding of 18-h rIL-1 beta or LPS-stimulated endothelial cells to purified p150,95 absorbed to plastic microtiter plates. These results indicate that p150,95 can function independently as an adhesion molecule and that it can interact with a counter-receptor on stimulated endothelium.
This article has been cited by other articles:
![]() |
C. Sadhu, H. J. Ting, B. Lipsky, K. Hensley, L. F. Garcia-Martinez, S. I. Simon, and D. E. Staunton CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity J. Leukoc. Biol., June 1, 2007; 81(6): 1395 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Bullard, X. Hu, J. E. Adams, T. R. Schoeb, and S. R. Barnum p150/95 (CD11c/CD18) Expression Is Required for the Development of Experimental Autoimmune Encephalomyelitis Am. J. Pathol., June 1, 2007; 170(6): 2001 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ihanus, L. M. Uotila, A. Toivanen, M. Varis, and C. G. Gahmberg Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4 Blood, January 15, 2007; 109(2): 802 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aranami, S. Miyake, and T. Yamamura Differential Expression of CD11c by Peripheral Blood NK Cells Reflects Temporal Activity of Multiple Sclerosis J. Immunol., October 15, 2006; 177(8): 5659 - 5667. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zen, M. Utech, Y. Liu, I. Soto, A. Nusrat, and C. A. Parkos Association of BAP31 with CD11b/CD18: POTENTIAL ROLE IN INTRACELLULAR TRAFFICKING OF CD11b/CD18 IN NEUTROPHILS J. Biol. Chem., October 22, 2004; 279(43): 44924 - 44930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zen, B. A. Babbin, Y. Liu, J. B. Whelan, A. Nusrat, and C. A. Parkos JAM-C Is a Component of Desmosomes and a Ligand for CD11b/CD18-mediated Neutrophil Transepithelial Migration Mol. Biol. Cell, August 1, 2004; 15(8): 3926 - 3937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. H. Lum, C. E. Green, G. R. Lee, D. E. Staunton, and S. I. Simon Dynamic Regulation of LFA-1 Activation and Neutrophil Arrest on Intercellular Adhesion Molecule 1 (ICAM-1) in Shear Flow J. Biol. Chem., May 31, 2002; 277(23): 20660 - 20670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rezzonico, V. Imbert, R. Chicheportiche, and J.-M. Dayer Ligation of CD11b and CD11c {beta}2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1{alpha} (MIP-1{alpha}) and MIP-1{beta} production in primary human monocytes through a pathway dependent on nuclear factor-{kappa}B Blood, May 15, 2001; 97(10): 2932 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shelly, L. Petruzzelli, and R. Herrera K562 Cells Resistant to Phorbol 12-Myristate 13-acetate-induced Growth Arrest: Dissociation of Mitogen-activated Protein Kinase Activation and Egr-1 Expression from Megakaryocyte Differentiation Cell Growth Differ., September 1, 2000; 11(9): 501 - 506. [Abstract] [Full Text] |
||||
![]() |
R. Rezzonico, R. Chicheportiche, V. Imbert, and J.-M. Dayer Engagement of CD11b and CD11c beta 2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways Blood, June 15, 2000; 95(12): 3868 - 3877. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Petersen, C. W. Smith, and A. L. Jensen Characterization of the Priming Effect by Pituitary Canine Growth Hormone on Canine Polymorphonuclear Neutrophil Granulocyte Function Clin. Vaccine Immunol., March 1, 2000; 7(2): 226 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Hentzen, S. Neelamegham, G. S. Kansas, J. A. Benanti, L. V. McIntire, C. W. Smith, and S. I. Simon Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1 Blood, February 1, 2000; 95(3): 911 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Stacker, A. Vitali, C. Caesar, T. Domagala, L. C. Groenen, E. Nice, M. G. Achen, and A. F. Wilks A Mutant Form of Vascular Endothelial Growth Factor (VEGF) That Lacks VEGF Receptor-2 Activation Retains the Ability to Induce Vascular Permeability J. Biol. Chem., December 3, 1999; 274(49): 34884 - 34892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Stacker, K. Stenvers, C. Caesar, A. Vitali, T. Domagala, E. Nice, S. Roufail, R. J. Simpson, R. Moritz, T. Karpanen, et al. Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers J. Biol. Chem., November 5, 1999; 274(45): 32127 - 32136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Halford, A. C. Oates, M. L. Hibbs, A. F. Wilks, and S. A. Stacker Genomic Structure and Expression of the Mouse Growth Factor Receptor Related to Tyrosine Kinases (Ryk) J. Biol. Chem., March 12, 1999; 274(11): 7379 - 7390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Sanz, L. Marinova-Mutafchieva, P. Green, R. R. Lobb, M. Feldmann, and S. Nourshargh IL-4-Induced Eosinophil Accumulation in Rat Skin Is Dependent on Endogenous TNF-{alpha} and {alpha}4 Integrin/VCAM-1 Adhesion Pathways J. Immunol., June 1, 1998; 160(11): 5637 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Petruzzelli, L. Maduzia, and T. A. Springer Differential Requirements for LFA-1 Binding to ICAM-1 and LFA-1-Mediated Cell Aggregation J. Immunol., May 1, 1998; 160(9): 4208 - 4216. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lopez-Rodriguez, L. Botella, and A. L. Corbi CCAAT-Enhancer-binding Proteins (C/EBP) Regulate the Tissue Specific Activity of the CD11c Integrin Gene Promoter Through Functional Interactions with Sp1 Proteins J. Biol. Chem., November 14, 1997; 272(46): 29120 - 29126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clark, H. P. Erickson, and T. A. Springer Tenascin Supports Lymphocyte Rolling J. Cell Biol., May 5, 1997; 137(3): 755 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zang and T. A. Springer Amino Acid Residues in the PSI Domain and Cysteine-rich Repeats of the Integrin beta 2 Subunit That Restrain Activation of the Integrin alpha xbeta 2 J. Biol. Chem., March 2, 2001; 276(10): 6922 - 6929. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |